A 2021 meta-analysis published in BMC Complementary Medicine and Therapies found consuming apple cider vinegar reduced fasting blood glucose by about 8 milligrams per deciliter in people with Type 2 diabetes whose glucose levels were higher to begin with
is supported by NIH research grants R01MD014712, U2CDK114886, UL1TR002319, U54DK083912, U01DK100846, OT2HL161847, UM1AI109568, OT2OD032581 and CDC project numbers 75D301-21-P-12254 and 75D301-23-C-18264
Concomitant diseases of patients in this trial included, but were not limited to, heart failure (12%), history of ischemic stroke (8%) and history of a MI (36%)
Across these trials, tirzepatide delivered dose-dependent improvements in glycemic control and body weight, often surpassing comparators like semaglutide and dulaglutide (43)(44)